Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pharmacokinetic changes in obesity]

E Girardin1, B Bruguerolle

  • 1Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine, Marseille.

Therapie
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of build orientation and element partitioning on microstructure and mechanical properties of biomedical Ti-6Al-4V alloy produced by laser sintering.

Journal of the mechanical behavior of biomedical materials·2017
Same author

Lactic acidosis: relationship between metformin levels, lactate concentration and mortality.

Diabetic medicine : a journal of the British Diabetic Association·2016
Same author

Effects of thermal treatments on microstructure and mechanical properties of a Co-Cr-Mo-W biomedical alloy produced by laser sintering.

Journal of the mechanical behavior of biomedical materials·2016
Same author

Structural characterization of biomedical Co-Cr-Mo components produced by direct metal laser sintering.

Materials science & engineering. C, Materials for biological applications·2015
Same author

Proteinuria Increases Plasma Phosphate by Altering Its Tubular Handling.

Journal of the American Society of Nephrology : JASN·2014
Same author

[Premature kidneys and oligonephronia: long term repercussion].

Revue medicale suisse·2014
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles

Obesity alters drug distribution and clearance by affecting body composition, protein binding, and organ function. Understanding these changes is crucial for calculating appropriate drug dosages in obese patients.

Area of Science:

  • Pharmacokinetics
  • Obesity Medicine
  • Drug Metabolism

Context:

  • Obesity is a prevalent condition with significant implications for drug pharmacokinetics.
  • Limited research exists on obesity-induced kinetic changes despite its frequency.
  • Body composition alterations in obesity impact drug distribution and efficacy.

Purpose:

  • To explore how obesity affects drug distribution, metabolism, and excretion.
  • To identify key factors influencing drug behavior in obese individuals.
  • To provide a basis for adjusting drug dosing in obesity.

Summary:

  • Obesity alters drug distribution due to changes in body composition and regional blood flow, affecting lipophilic drug diffusion.
  • Protein binding of basic drugs increases with elevated alpha-1-acid glycoprotein levels in obesity.

Related Experiment Videos

  • Hepatic and renal clearance pathways are modified in obesity, with some metabolic reactions increasing and others remaining unchanged.
  • Drug clearance and lipophilicity are key parameters for calculating loading and maintenance doses in obese patients.

    • Impact:

    • Highlights the need for individualized drug dosing strategies in obese populations.
    • Informs clinical practice regarding medication management for obesity.
    • Guides future research into obesity pharmacokinetics and therapeutic interventions.